A rare cancer needs a rare champion.
January is National Cervical Cancer Awareness Month. According to the National Cancer Institute, last year this terrible disease caused more than 4,000 deaths in the U.S., and nearly 13,000 new cases emerged. Fortunately, the institutions of the Big Ten Cancer Research Consortium invest time, energy and resources into fighting this avoidable and treatable malady in this country and around the world. Here’s a look at some of the important work happening at Big Ten universities. Wisconsin Because of advanced detection and surgical techniques, cervical cancer is often treatable in the U.S. But developing countries like Bangladesh, it’s commonly among the
It’s Breast Cancer Awareness Month, and the pink ribbons (and shirts, and stickers) are out in force. And the Big Ten Cancer Research Consortium (BTCRC) is commemorating the month by highlighting innovative and important work the universities of the conference are doing year-round to fight this terrible disease. Read about some of that work below: University of Illinois Until now, the study of cancerous tumor cells is hindered by an important factor: environment. The most common tool for studying the growth and spread of a tumor has been a plastic plate that doesn’t mimic the human body. But recently, the
Spring Break has slowed down activities on many university campuses recently, but members of the Big Ten Cancer Research Consortium (BTCRC), an organization that unites the cancer centers and medical schools of all the universities in the conference, haven’t slowed down in their fight against this destructive disease. Here’s a look at the latest updates from some of the universities around the Big Ten: University of Wisconsin University of Wisconsin medical professors John S. Kuo, M.D., Ph.D., and Jamey Weichert, Ph.D., are spreading the word on new ways to monitor a particularly deadly form of cancer. They appeared on the
A couple of weeks ago, basketball coaches across the Big Ten Conference made a fashion statement of sorts. They donned snazzy sneakers on the hardwood, even though many of them were wearing suits and ties, to take part in Coaches vs. Cancer, a nationwide campaign that annually draws public attention to advocacy and fundraising efforts around this severe disease. The conference comes together to fight cancer in other ways as well. One of the most notable is the Big Ten Cancer Research Consortium (BTCRC), an initiative that enables the sharing of research and resources among the cancer centers and medical
Claiming more than half a million lives per year, cancer is the second-leading cause of death in the United States, right behind heart disease. More people die from some form of cancer than the next three causes (chronic respiratory diseases, stroke and various accidents) combined. The cancer centers of member universities of the Big Ten teamed up to combat this deadly affliction. The Big Ten Cancer Research Consortium (BTCRC), which was little more than an idea in 2011, began its clinical trial working groups last year, and it’s stepping up on sharing information about the various major initiatives of the
Click here to read BTN LiveBIG’s introduction of the Big Ten Cancer Research Consortium. The cancer centers at 12 of the schools in the Big Ten have joined forces to create the Big Ten Cancer Research Consortium (CRC), a collaboration on the study of cancer with an aim toward eventually finding a cure. BTN LiveBig interviewed three cancer center directors working with the CRC to discuss the benefits of a collaborative approach to medical research. We sat down with Dr. Robert DiPaola, Rutgers Cancer Institute of New Jersey; Dr. Patrick Loehrer, Indiana University Melvin and Bren Simon Cancer Center; and
Every Big Ten school has doctors and students doing research into the causes and potential cures of cancer. Those efforts are now part of a coordinated system of research known as the Big Ten Cancer Research Consortium. “The premise of the Big Ten Cancer Research Consortium is to provide a unified network of high-level academic institutions working together for the conduct of novel science-driven clinical trials which incorporate major bench-to-bedside and back translational components arising from the labs and departments of our various centers,’’ said Dr. Noah Hahn, former executive officer of the Big Ten CRC. “There is a big